Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.03
-0.52-5.45%
Last update: Oct 13, 3:59 PM
$9.48
-0.07-0.73%
DBV Technologies SA (DBVT) Stock Price, Quote, News & History
DBVTNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of DBV Technologies (NASDAQ:DBVT) through any online brokerage.
Other companies in DBV Technologies’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
DBV Technologies has a consensus price target of $27.32.
The stock price for DBV Technologies (NASDAQ: DBVT) is $9.0172 last updated October 13, 2026 at 3:59 PM EDT.
There are no upcoming dividends for DBV Technologies.
DBV Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for DBV Technologies.
DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
